Skip to main content
SpringerLink
Log in

Uso del sequenziamento del ctDNA per la rilevazione precoce della recidiva di malattia in un paziente con tumore timico metastatico e mosaicismo MEN1

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Santos V, Freitas C, Fernandes MG et al. (2022) Liquid biopsy: the value of different bodily fluids. Biomark Med 2:127–145

    Article  Google Scholar 

  2. Pantel K, Alix-Panabières C (2019) Liquid biopsy and minimal residual disease – latest advances and implications for cure. Nat Rev Clin Oncol 7:409–424

    Article  Google Scholar 

  3. Markou A, Tzanikou E, Lianidou E (2022) The potential of liquid biopsy in the management of cancer patients. Semin Cancer Biol 84:69–79

    Article  CAS  PubMed  Google Scholar 

  4. Rolfo C, Mack P, Scagliotti GV et al. (2021) Liquid biopsy for advanced NSCLC: a consensus statement from the International Association for the Study of Lung Cancer. J Thorac Oncol 10:1647–1662

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratorio di Oncologia, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italia

    Lucia Anna Muscarella

  2. Divisione di Genetica Medica, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG), Italia

    Vito Guarnieri

Authors
  1. Lucia Anna Muscarella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vito Guarnieri
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Conflitto di interessi

Gli Autori dichiarano di non avere conflitti di interesse.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muscarella, L.A., Guarnieri, V. Uso del sequenziamento del ctDNA per la rilevazione precoce della recidiva di malattia in un paziente con tumore timico metastatico e mosaicismo MEN1. L'Endocrinologo 24, 206–207 (2023). https://doi.org/10.1007/s40619-023-01251-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-023-01251-4

Search

Navigation